Search Results 51-60 of 37887 for Two-phase

  1. Clinical trials - Oncology (Medical)

    ... Phase 2 dose (RP2D) and schedule of KTX-1001 for ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  2. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    About this study. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab ...

  3. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma - Mayo Clinic

    A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy ...

  4. A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer - Mayo Clinic

    A Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients. Participation eligibility.

  5. Clinical trials - Oncology (Medical)

    ... Phase 2 dose (RP2D) and schedule of KTX-1001 for ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  6. It allows the baby to move into the birth canal. The first stage of labor is the longest of the three stages. It's divided into two phases — early labor and ...

  7. Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy - Mayo Clinic

    The secondary efficacy objective is to assess the effects of natalizumab versus placebo in drug-resistant focal epilepsy on additional measures of seizure ...

  8. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    TP-0903 is shown to block cancer cell epithelial-to-mesenchymal transitions. AXL was identified as a potential therapeutic target in chronic lymphocytic ...

  9. Clinical trials - Oncology (Medical)

    ... phase II dose (RP2D of APG2575 in combination with ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  10. Clinical trials - Oncology (Medical)

    The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II will ...